Digital Dose Inhaler Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Cerebral Vascular Stent Market Growth and the Market is Segmented by Type (Self-expanding Stents, Balloon Expanding Stents, and Stent-assisted Coil Embolization), Application (Intracranial Stenosis and Brain Aneurysm), End User (Hospitals, Ambulatory Surgery Centers and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Digital Dose Inhaler Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Digital Dose Inhaler Market Size

Digital Dose Inhaler Market Size
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 13.30 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Global Digital Dose Inhaler Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Digital Dose Inhaler Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Digital Dose Inhaler Market Analysis

The Global Digital Dose Inhaler Market is expected to register a CAGR of 13.3% during the forecast period.

COVID-19 pandemic had a significant impact on the global digital dose inhaler market, due to patients with asthma and chronic obstructive pulmonary disease (COPD) being considered at increased risk of hospitalization from COVID-19. According to the article titled "Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study" published in January 2022 adults with asthma were found to be at an increased risk of COVID-19 hospital admission compared with those without asthma conditions. Thus, increasing cases of COVID-19 are rising the cases of respiratory disorders which generates the need for digital dose inhalers. Thus COVID-19 had a significant impact on the growth of the market during the pandemic period.

The major factors attributing to the growth of the digital dose inhaler market include the rising prevalence of chronic respiratory diseases and the growing demand for technology-enabled features of respiratory devices.

Soaring geriatric populations suffering from respiratory disorders and favorable reimbursement policies also play a significant role in the growth of the market. According to the article titled "Common Respiratory Disorders in Seniors" published in April 2020 around 15% of older adults from asthma, chronic obstructive pulmonary disease, or another respiratory disorder. The rising prevalence of respiratory diseases globally is expected to drive the demand for digital dose inhalers, thereby contributing to the growth of the market.

Additionally, the increasing product launches are expected to contribute to the growth of the market. For instance, in December 2021 NuvoAir, launched an add-on sensor for asthma and chronic obstructive pulmonary disease inhalers as a part of its chronic care ecosystem.

Thus, the above-mentioned factors are expected to drive the growth of the market over the forecast period. However, the high cost of the inhalers is a constraint to the growth of the market.

Digital Dose Inhaler Industry Overview

The digital dose inhaler market is moderately competitive and consists of key market players. Some of the companies which are currently dominating the market include Glenmark Pharmaceuticals Ltd., AstraZeneca Plc, Novartis International AG, Propeller Health, Philips Respironics, Opko Health, Inc., and Teva Pharmaceutical Industries Ltd.

Digital Dose Inhaler Market Leaders

  1. Propeller Health

  2. Koninklijke Philips N.V.

  3. Novartis International AG

  4. Teva Pharmaceuticals Inc.,

  5. *Disclaimer: Major Players sorted in no particular order
Digital - MC.jpg
Need More Details on Market Players and Competiters?
Download PDF

Digital Dose Inhaler Market News

  • In February 2022 Astrazeneca and Honeywell partnered to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less global warming potential than propellants currently used in respiratory medicines.
  • In February 2022, Aptar Pharma launched HeroTracker Sense, a novel digital respiratory health solution that transforms a standard metered dose inhaler into a smart connected healthcare device.

Digital Dose Inhaler Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Respiratory Diseases
    • 4.2.2 Soaring Geriatric Population Afflicted With Respiratory Disorders
    • 4.2.3 Increasing R&D Investment for Technological Improvement and Device Miniaturization
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Dry Powder Inhalers
    • 5.1.2 Metered Dose Inhalers
  • 5.2 By Application
    • 5.2.1 Chronic Obstructive Pulmonary Disease
    • 5.2.2 Asthma
    • 5.2.3 Others
  • 5.3 By Type
    • 5.3.1 Branded
    • 5.3.2 Generic
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Glenmark Pharmaceuticals
    • 6.1.2 Novartis International AG
    • 6.1.3 Propeller Health
    • 6.1.4 Koninklijke Philips N.V.
    • 6.1.5 Opko Health, Inc.
    • 6.1.6 Teva Pharmaceutical Industries Ltd.
    • 6.1.7 H&T Presspart Manufacturing Ltd
    • 6.1.8 AptarGroup Inc
    • 6.1.9 Amiko Digital Health Limited
    • 6.1.10 Pneuma Respiratory
    • 6.1.11 Trudell Medical UK Limited
    • 6.1.12 BreatheSuite Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Digital Dose Inhaler Industry Segmentation

As per the scope of the report, digital dose inhalers are devices that deliver a specific amount of medication to the lungs in the form of aerosolized medicine or dry powder. The Digital Dose Inhaler Market is Segmented by Product (Dry Powder Inhalers and Metered Dose Inhalers), Application (Chronic Obstructive Pulmonary Disease, Asthma and Others), Type (Branded and Generic), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Dry Powder Inhalers
Metered Dose Inhalers
By Application Chronic Obstructive Pulmonary Disease
Asthma
Others
By Type Branded
Generic
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Digital Dose Inhaler Market Research FAQs

What is the current Global Digital Dose Inhaler Market size?

The Global Digital Dose Inhaler Market is projected to register a CAGR of 13.3% during the forecast period (2025-2030)

Who are the key players in Global Digital Dose Inhaler Market?

Propeller Health, Koninklijke Philips N.V., Novartis International AG and Teva Pharmaceuticals Inc., are the major companies operating in the Global Digital Dose Inhaler Market.

Which is the fastest growing region in Global Digital Dose Inhaler Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Digital Dose Inhaler Market?

In 2025, the North America accounts for the largest market share in Global Digital Dose Inhaler Market.

What years does this Global Digital Dose Inhaler Market cover?

The report covers the Global Digital Dose Inhaler Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Digital Dose Inhaler Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Digital Dose Inhaler Industry Report

Statistics for the 2025 Global Digital Dose Inhaler market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Digital Dose Inhaler analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Digital Dose Inhaler Market Report Snapshots